-+ 0.00%
-+ 0.00%
-+ 0.00%

PHASE III TRIAL SHOWS VERACYTE’S DECIPHER PROSTATE TEST CAN PREDICT BENEFIT FROM ADDING ABIRATERONE TO TREATMENT IN VERY HIGH-RISK PROSTATE CANCER

Reuters·10/23/2026 08:02:12